Emily A. Hull-Ryde

2.3k total citations
27 papers, 1.6k citations indexed

About

Emily A. Hull-Ryde is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Emily A. Hull-Ryde has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Emily A. Hull-Ryde's work include Peroxisome Proliferator-Activated Receptors (6 papers), Adenosine and Purinergic Signaling (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Emily A. Hull-Ryde is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Adenosine and Purinergic Signaling (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Emily A. Hull-Ryde collaborates with scholars based in United States, Canada and Russia. Emily A. Hull-Ryde's co-authors include James M. Lenhard, Steven G. Blanchard, Jon L. Collins, Derek J. Parks, Kelli D. Plunket, Timothy M. Willson, Jeff E. Cobb, Robin G. Cummings, Lisa M. Leesnitzer and James E. Lowe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Emily A. Hull-Ryde

26 papers receiving 1.6k citations

Peers

Countries citing papers authored by Emily A. Hull-Ryde

Since Specialization

Citations

This map shows the geographic impact of Emily A. Hull-Ryde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Hull-Ryde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Hull-Ryde more than expected).

Fields of papers citing papers by Emily A. Hull-Ryde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Hull-Ryde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Hull-Ryde. The network helps show where Emily A. Hull-Ryde may publish in the future.

Co-authorship network of co-authors of Emily A. Hull-Ryde

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Hull-Ryde. A scholar is included among the top collaborators of Emily A. Hull-Ryde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Hull-Ryde. Emily A. Hull-Ryde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation 2022 ·Current Opinion in Pharmacology ·Carla M. P. Ribeiro, Emily A. Hull-Ryde	4
2	IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation 2021 ·International Journal of Molecular Sciences ·Emily A. Hull-Ryde, John T. Minges, (unknown), Takafumi Kato, Jacqueline L. Norris‐Drouin, Carla M. P. Ribeiro	11
3	Orally Active Adenosine A 1 Receptor Agonists with Antinociceptive Effects in Mice 2020 ·UNC Libraries ·Ilia Korboukh, Vincent Setola, (unknown), Stephen V. Frye, Jian Jin, Jennifer A. Coleman, William P. Janzen, (unknown), Joseph E. Rittiner, Mark J. Zylka, Emily A. Hull-Ryde	0
4	XBP1S Regulates MUC5B in a Promoter Variant–Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia 2019 ·American Journal of Respiratory and Critical Care Medicine ·Gang Chen, Carla M. P. Ribeiro, Ling Sun, Kenichi Okuda, Takafumi Kato, Rodney C. Gilmore, (unknown), Hong Dang, (unknown), (unknown), Emily A. Hull-Ryde, A.S. Volmer, Scott H. Randell, Alessandra Livraghi-Butrico, Yingfeng Deng, Philipp E. Scherer, Barry R. Stripp, Wanda K. O’Neal, Richard C. Boucher	45
5	Identification of Cosalane as an Inhibitor of Human and Murine CC–Chemokine Receptor 7 Signaling via a High-Throughput Screen 2018 ·SLAS DISCOVERY ·Emily A. Hull-Ryde, (unknown), Kenneth A. Fowler, Dmitri Kireev, Kelin Li, Catherine Simpson, Maria F. Sassano, Mark J. Suto, Kenneth H. Pearce, William P. Janzen, James M. Coghill	12
6	Instrument Quality Control 2016 ·Methods in molecular biology ·(unknown), Emily A. Hull-Ryde	1
7	High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides 2015 ·Nucleic Acids Research ·Bing Yang, Xin Ming, Canhong Cao, Brian Laing, Ahu Yuan, (unknown), Emily A. Hull-Ryde, Joseph A. Maddry, Mark J. Suto, William P. Janzen, R. L. Juliano	77
8	Identification of Small Molecule Inhibitors That Block the Toxoplasma gondii Rhoptry Kinase ROP18 2015 ·ACS Infectious Diseases ·Catherine Simpson, Nathaniel G. Jones, Emily A. Hull-Ryde, Dmitri Kireev, Michael A. Stashko, Keliang Tang, James W. Janetka, Scott A. Wildman, William J. Zuercher, Matthieu Schapira, Raymond Hui, William P. Janzen, L. David Sibley	9
9	Tackling reproducibility in academic preclinical drug discovery 2015 ·Nature Reviews Drug Discovery ·Stephen V. Frye, Michelle R. Arkin, C.H. Arrowsmith, P. Jeffrey Conn, Marcie A. Glicksman, Emily A. Hull-Ryde, Barbara S. Slusher	39
10	Filtration Improves the Performance of a High-Throughput Screen for Anti-Mycobacterial Compounds 2014 ·PLoS ONE ·Nancy Cheng, (unknown), Lloyd Frick, (unknown), Jennifer Hayden, Ellen Young, Miriam Braunstein, Emily A. Hull-Ryde, William P. Janzen	11
11	Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C 2014 ·SLAS DISCOVERY ·(unknown), Catherine Simpson, Michael A. Stashko, Dmitri Kireev, Emily A. Hull-Ryde, Mark J. Zylka, William P. Janzen	16
12	Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs 2013 ·SLAS TECHNOLOGY ·Nancy Cheng, Sook-Kyung Lee, Preston S. Donover, (unknown), Celia A. Schiffer, Emily A. Hull-Ryde, Ronald Swanstrom, William P. Janzen	6
13	A Sensitive Assay Using a Native Protein Substrate for Screening HIV-1 Maturation Inhibitors Targeting the Protease Cleavage Site between the Matrix and Capsid 2013 ·Biochemistry ·Sook-Kyung Lee, Nancy Cheng, Emily A. Hull-Ryde, Marc Potempa, Celia A. Schiffer, William P. Janzen, Ronald Swanstrom	8
14	AMP Is an Adenosine A1 Receptor Agonist 2012 ·Journal of Biological Chemistry ·Joseph E. Rittiner, Ilia Korboukh, Emily A. Hull-Ryde, Jian Jin, William P. Janzen, Stephen V. Frye, Mark J. Zylka	108
15	Orally Active Adenosine A₁Receptor Agonists with Antinociceptive Effects in Mice 2012 ·Journal of Medicinal Chemistry ·Ilia Korboukh, Emily A. Hull-Ryde, Joseph E. Rittiner, (unknown), (unknown), (unknown), Vincent Setola, William P. Janzen, Stephen V. Frye, Mark J. Zylka, Jian Jin	22
16	High-Affinity Monoclonal Antibodies to PED/PEA-15 Generated Using 5 μg of DNA 2000 ·Hybridoma ·Katherine E. Kilpatrick, Dana P. Danger, Emily A. Hull-Ryde, W S Dallas	10
17	Use of a PPAR Gamma-Specific Monoclonal Antibody to Demonstrate Thiazolidinediones Induce PPAR Gamma Receptor Expression In Vitro 1999 ·Hybridoma ·Jui‐Lan Su, Deborah A. Winegar, G. Bruce Wisely, Carlie Sigel, Emily A. Hull-Ryde	9
18	Development of Infrared Imaging to Measure Thermogenesis in Cell Culture: Thermogenic Effects of Uncoupling Protein-2, Troglitazone, and β-Adrenoceptor Agonists 1998 ·Pharmaceutical Research ·Mark Paulik, Richard G. Buckholz, Mary E. Lancaster, (unknown), Emily A. Hull-Ryde, James E. Weiel, James M. Lenhard	74
19	Protective metabolic effects of propranolol during total myocardial ischemia 1986 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), William R. Lewis, (unknown), Emily A. Hull-Ryde, James E. Lowe	7
20	Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension. 1983 ·Circulation ·J. E. Lowe, Robin G. Cummings, David Adams, Emily A. Hull-Ryde	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact